Donation after circulatory death transplant outcomes using livers recovered by local surgeons [0.03%]
当地外科医生获取器官的循环死亡捐献肝移植效果分析
Caroline C Jadlowiec,Elizabeth Macdonough,Kylie Pont et al.
Caroline C Jadlowiec et al.
Donation after circulatory death (DCD) liver transplantation (LT) outcomes have been attributed to multiple variables, including procurement surgeon recovery techniques. Outcomes of 196 DCD LTs at Mayo Clinic Arizona were analyzed based on ...
Cirrhotic cardiomyopathy: Appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes [0.03%]
肝硬化心肌病：评估原始和修订标准在预测移植后心脏结局方面的价值
Ashley Spann,Christopher Coe,Teminioluwa Ajayi et al.
Ashley Spann et al.
Cardiovascular disease (CVD) significantly contributes to morbidity and mortality after liver transplantation (LT). Cirrhotic cardiomyopathy (CCM) is a risk factor for CVD after transplant. CCM criteria were originally introduced in 2005 wi...
Preservation solutions for static cold storage in donation after circulatory death and donation after brain death liver transplantation in the United States [0.03%]
美国公民死后的肝脏移植中的捐献保存解决方案比较研究
Thomas G Cotter,Matthew A Odenwald,Angelica Perez-Gutierrez et al.
Thomas G Cotter et al.
Static cold preservation remains the cornerstone for storing donor livers following procurement; however, the choice between University of Wisconsin solution (UW) and histidine-tryptophan-ketoglutarate solution (HTK) remains controversial. ...
Acute cellular rejection in liver transplantation recipients following coronavirus disease 2019 vaccination [0.03%]
肝移植受者接种新型冠状病毒疫苗后出现急性细胞排斥反应
Rujittika Mungmunpuntipantip,Viroj Wiwanitkit
Rujittika Mungmunpuntipantip
Donor-recipient human leukocyte antigen A mismatching is associated with hepatic artery thrombosis, sepsis, graft loss, and reduced survival after liver transplant [0.03%]
供者-受者人类白细胞抗原A不匹配与肝移植后肝动脉血栓形成、败血症、移植物丢失和生存率降低有关
Christopher Bricogne,Neil Halliday,Raymond Fernando et al.
Christopher Bricogne et al.
Human leukocyte antigen (HLA) matching is not routinely performed for liver transplantation as there is no consistent evidence of benefit; however, the impact of HLA mismatching remains uncertain. We explored the effect of class I and II HL...
Ehab E Abdel-Khalek,Mohamed Abdel-Wahab,Mohamed H Elgazzar et al.
Ehab E Abdel-Khalek et al.
Living donors are healthy individuals who are exposed to a major surgical procedure during which a major part of their liver is resected. Data on the long-term consequences of living liver donation are scarce. This study examined clinical, ...
Mammalian Target of Rapamycin and Hepatocellular Carcinoma: The Question's Always There, Until We Choose To Answer It [0.03%]
雷帕霉素靶蛋白与肝细胞癌研究：问题一直都在，只待我们发现并解答它
Christopher J Danford,Richard Gilroy
Christopher J Danford
The fundamentals of sex-based disparity in liver transplantation: Understanding can lead to change [0.03%]
肝移植中基于性别的差异的基本原则——理解可以带来改变
Noreen Singh,Kymberly D Watt,Rahima A Bhanji
Noreen Singh
Liver transplantation (LT) is the definitive treatment for end-stage liver disease. Unfortunately, women are disadvantaged at every stage of the LT process. We conducted a literature review to increase the understanding of this disparity. H...
Prediction of long-term morbidity and mortality after liver transplantation using two-dimensional shear wave elastography compared with liver biopsy [0.03%]
二维剪切波弹性成像与肝活检对比预测肝移植后长期疾病发病率和死亡率
Mohammad Amin Fallahzadeh,Sumeet K Asrani,Elham Vahhab et al.
Mohammad Amin Fallahzadeh et al.
The role of noninvasive liver disease assessment by two-dimensional shear wave elastography (2D-SWE) to diagnose fibrosis is well described in patients with chronic liver disease. However, its role in prognosis, especially after liver trans...